User talk:Rkhaarma
Your submission at Articles for creation
[edit]Reliv, which you submitted to Articles for creation, has been created.
- Please continue making quality contributions to Wikipedia. Note that because you are a logged-in user, you can create articles yourself, and don't have to post a request.
- If you would like to help us improve this process, please consider
Thank you for helping Wikipedia! Chzz ► 02:48, 13 September 2010 (UTC)
Your submission at Articles for creation
[edit]- If you would like to continue working on the submission, you can find it at Wikipedia talk:Articles for creation/Mallinckrodt Pharmaceuticals.
- To edit the submission, click on the "Edit" tab at the top of the window.
- If you need any assistance, you can ask for help at the Articles for creation help desk, or on the . Please remember to link to the submission!
- You can also get live chat help from experienced editors.
- Thank you for your contributions to Wikipedia! Kinu t/c 09:08, 20 March 2013 (UTC)
Reply to your Articles for Creation Help Desk question on Mallinckrodt Pharmaceuticals
[edit] Hello, Rkhaarma! I'm Huon. I have replied to your question on the Articles for Creation Help Desk about Mallinckrodt Pharmaceuticals.
You can read it at Wikipedia:WikiProject Articles for creation/Help desk#Review of Wikipedia talk:Articles for creation/Mallinckrodt Pharmaceuticals. Huon (talk) 20:25, 20 March 2013 (UTC)
Hi there, I'm HasteurBot. I just wanted to let you know that Wikipedia talk:Articles for creation/Mallinckrodt Pharmaceuticals, a page you created, has not been edited in 6 months. The Articles for Creation space is not an indefinite storage location for content that is not appropriate for articlespace.
If your submission is not edited soon, it could be nominated for deletion. If you would like to attempt to save it, you will need to improve it.
You may request Userfication of the content if it meets requirements.
If the deletion has already occured, instructions on how you may be able to retrieve it are available at WP:REFUND/G13.
Thank you for your attention. HasteurBot (talk) 02:07, 21 September 2013 (UTC)
Your draft article, Wikipedia talk:Articles for creation/Mallinckrodt Pharmaceuticals
[edit]Hello Rkhaarma. It has been over six months since you last edited your WP:AFC draft article submission, entitled "Mallinckrodt Pharmaceuticals".
The page will shortly be deleted. If you plan on editing the page to address the issues raised when it was declined and resubmit it, simply {{db-afc}}
or {{db-g13}}
code. Please note that Articles for Creation is not for indefinite hosting of material deemed unsuitable for the encyclopedia mainspace.
If your submission has already been deleted by the time you get there, and you want to retrieve it, copy this code: {{subst:Refund/G13|Wikipedia talk:Articles for creation/Mallinckrodt Pharmaceuticals}}
, paste it in the edit box at this link, click "Save", and an administrator will in most cases undelete the submission.
Thanks for your submission to Wikipedia, and happy editing. HasteurBot (talk) 18:02, 16 January 2014 (UTC)
Response from Rkhaarma to HasteurBot
[edit]Thanks for bringing this to my attention. I actually followed the original recommendation of editors who advised me to make my edits to the existing page instead of creating a new one. If I understand correctly, you are stating that the article that was submitted to editors for review will be deleted, not the article that is posted. Is that correct? I just want to make sure I understand correctly. I did not know I needed to delete my submission that I had sent to the editors. I will delete it ASAP, once I get clarification that it will not delete the article in the encyclopedia itself. Rkhaarma (talk) 18:14, 16 January 2014 (UTC)
A discussion is taking place as to whether the article Reliv is suitable for inclusion in Wikipedia according to Wikipedia's policies and guidelines or whether it should be deleted.
The article will be discussed at Wikipedia:Articles for deletion/Reliv until a consensus is reached, and anyone is welcome to contribute to the discussion. The nomination will explain the policies and guidelines which are of concern. The discussion focuses on high-quality evidence and our policies and guidelines.
Users may edit the article during the discussion, including to improve the article to address concerns raised in the discussion. However, do not remove the article-for-deletion notice from the top of the article. Galobtter (pingó mió) 14:28, 25 April 2018 (UTC)